LobbyingBirmingham Bio Innovation lobbying by quarter
Birmingham Bio Innovation's latest lobbying report covers Q3 2024, at $5,000. Its first report covers Q1 2024; the issues it reports most are Economics/Economic Development and Science/Technology.
Birmingham Bio Innovation
- Latest quarter
- No record
- Q2 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q2 2026 against the quarter before
- First report
- Q1 2024
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2024 | $12.5K | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $5,000 | 1 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
Policy issues the reports name
- Economic development1 reports
- Science and technology1 reports
A report that names several issues counts once for each.
Who was lobbied
- Minority Business Development Agency1 reports
- White House Office1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Tusk Strategies | $17.5K | 3 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 24/10/07for Q3 2024 | Tusk Strategies | $5,000 |
| 24/06/27for Q2 2024 | Tusk Strategies | Under $5,000 |
| 24/04/09for Q1 2024 | Tusk Strategies | $12.5K |
| 24/02/28for Q1 2024 | Tusk Strategies | Under $5,000 |
| 24/02/27for Q1 2024 | Tusk Strategies | Under $5,000 |